Research Subject Injury Compensation: The Ongoing Search for Fairness,Consistency and Clarity

Abstract

Get full access to this article

View all access options for this article.

References

C. R

Chapman ,

Sukumaran ,

G. T.

Tsegaye ,

Shevchenko , and

A. L

Caplan , “The Quest for Compensation for Research-Related Injury in the United States: A New Proposal,” Journal of Law, Medicine & Ethics 47, no. 4 (2019): 732-747.

New Drugs and Clinical Trials Rules, 2018, Ministry of Health and Family Welfare, G.S.R. 104(E) (Feb. 1, 2018).

G. R

Chingarande and

Moodley , “Disparate Compensation Policies for Research Related Injury in an Era of Multinational Trials: A Case Study of Brazil, Russia, India, China and South Africa,” BMC Medical Ethics (2018), available at <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816510/> (last visited November 13, 2019).

See id. (“There is need for consistency and even harmonization of such regulations at a global level. A model policy on compensation for research related injuries should borrow from the best aspects of the different policies of the BRICS countries and should be informed by the cardinal ethics principles of autonomy, justice and beneficence.”)